Literature DB >> 20643647

Molecular characterization of N-acetylaspartylglutamate synthetase.

Ivonne Becker1, Julia Lodder, Volkmar Gieselmann, Matthias Eckhardt.   

Abstract

The dipeptide N-acetylaspartyl-glutamate (NAAG) is an abundant neuropeptide in the mammalian brain. Despite this fact, its physiological role is poorly understood. NAAG is synthesized by a NAAG synthetase catalyzing the ATP-dependent condensation of N-acetylaspartate and glutamate. In vitro NAAG synthetase activity has not been described, and the enzyme has not been purified. Using a bioinformatics approach we identified a putative dipeptide synthetase specifically expressed in the nervous system. Expression of the gene, which we named NAAGS (for NAAG synthetase) was sufficient to induce NAAG synthesis in primary astrocytes or CHO-K1 and HEK-293T cells when they coexpressed the NAA transporter NaDC3. Furthermore, coexpression of NAAGS and the recently identified N-acetylaspartate (NAA) synthase, Nat8l, in CHO-K1 or HEK-293T cells was sufficient to enable these cells to synthesize NAAG. Identity of the reaction product of NAAGS was confirmed by HPLC and electrospray ionization tandem mass spectrometry (ESI-MS). High expression levels of NAAGS were restricted to the brain, spinal cord, and testis. Taken together our results strongly suggest that the identified gene encodes a NAAG synthetase. Its identification will enable further studies to examine the role of this abundant neuropeptide in the vertebrate nervous system.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20643647      PMCID: PMC2937946          DOI: 10.1074/jbc.M110.111765

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

1.  Glutathione synthetase homologs encode alpha-L-glutamate ligases for methanogenic coenzyme F420 and tetrahydrosarcinapterin biosyntheses.

Authors:  Hong Li; Huimin Xu; David E Graham; Robert H White
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-08       Impact factor: 11.205

2.  Transport of N-acetylaspartate by the Na(+)-dependent high-affinity dicarboxylate transporter NaDC3 and its relevance to the expression of the transporter in the brain.

Authors:  W Huang; H Wang; R Kekuda; Y J Fei; A Friedrich; J Wang; S J Conway; R S Cameron; F H Leibach; V Ganapathy
Journal:  J Pharmacol Exp Ther       Date:  2000-10       Impact factor: 4.030

3.  Binding of Clostridium botulinum C2 toxin to asparagine-linked complex and hybrid carbohydrates.

Authors:  M Eckhardt; H Barth; D Blöcker; K Aktories
Journal:  J Biol Chem       Date:  2000-01-28       Impact factor: 5.157

4.  beta-NAAG rescues LTP from blockade by NAAG in rat dentate gyrus via the type 3 metabotropic glutamate receptor.

Authors:  P M Lea; B Wroblewska; J M Sarvey; J H Neale
Journal:  J Neurophysiol       Date:  2001-03       Impact factor: 2.714

5.  Glutamate carboxypeptidase II is expressed by astrocytes in the adult rat nervous system.

Authors:  U V Berger; R Luthi-Carter; L A Passani; S Elkabes; I Black; C Konradi; J T Coyle
Journal:  J Comp Neurol       Date:  1999-12-06       Impact factor: 3.215

6.  Synthesis and release of N-acetylaspartylglutamate (NAAG) by crayfish nerve fibers: implications for axon-glia signaling.

Authors:  A K Urazaev; R M Grossfeld; P L Fletcher; H Speno; B S Gafurov; J G Buttram; E M Lieberman
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

Review 7.  Functions of N-acetyl-L-aspartate and N-acetyl-L-aspartylglutamate in the vertebrate brain: role in glial cell-specific signaling.

Authors:  M H Baslow
Journal:  J Neurochem       Date:  2000-08       Impact factor: 5.372

8.  The cloning and characterization of a second brain enzyme with NAAG peptidase activity.

Authors:  Tomasz Bzdega; Samantha L Crowe; Epolia R Ramadan; Kathryn H Sciarretta; Rafal T Olszewski; Olumide A Ojeifo; Victoria A Rafalski; Barbara Wroblewska; Joseph H Neale
Journal:  J Neurochem       Date:  2004-05       Impact factor: 5.372

9.  Severe hypomyelination associated with increased levels of N-acetylaspartylglutamate in CSF.

Authors:  N I Wolf; M A A P Willemsen; U F Engelke; M S van der Knaap; P J W Pouwels; I Harting; J Zschocke; E A Sistermans; D Rating; R A Wevers
Journal:  Neurology       Date:  2004-05-11       Impact factor: 9.910

10.  SH-SY5Y neuroblastoma cells: a model system for studying biosynthesis of NAAG.

Authors:  Peethambaran Arun; Chikkathur N Madhavarao; Jeremy R Hershfield; John R Moffett; M A Aryan Namboodiri
Journal:  Neuroreport       Date:  2004-05-19       Impact factor: 1.837

View more
  25 in total

Review 1.  Glutamate carboxypeptidase II in diagnosis and treatment of neurologic disorders and prostate cancer.

Authors:  C Bařinka; C Rojas; B Slusher; M Pomper
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

Review 2.  Advances in understanding the peptide neurotransmitter NAAG and appearance of a new member of the NAAG neuropeptide family.

Authors:  Joseph H Neale; Rafal T Olszewski; Daiying Zuo; Karolina J Janczura; Caterina P Profaci; Kaleen M Lavin; John C Madore; Tomasz Bzdega
Journal:  J Neurochem       Date:  2011-07-01       Impact factor: 5.372

3.  N-acetylaspartate (NAA) and N-acetylaspartylglutamate (NAAG) promote growth and inhibit differentiation of glioma stem-like cells.

Authors:  Patrick M Long; John R Moffett; Aryan M A Namboodiri; Mariano S Viapiano; Sean E Lawler; Diane M Jaworski
Journal:  J Biol Chem       Date:  2013-07-24       Impact factor: 5.157

4.  N-acetylaspartylglutamate synthetase II synthesizes N-acetylaspartylglutamylglutamate.

Authors:  Julia Lodder-Gadaczek; Ivonne Becker; Volkmar Gieselmann; Lihua Wang-Eckhardt; Matthias Eckhardt
Journal:  J Biol Chem       Date:  2011-03-25       Impact factor: 5.157

5.  Group II mGluR agonist LY354740 and NAAG peptidase inhibitor effects on prepulse inhibition in PCP and D-amphetamine models of schizophrenia.

Authors:  Caterina P Profaci; Kristyn A Krolikowski; Rafal T Olszewski; Joseph H Neale
Journal:  Psychopharmacology (Berl)       Date:  2011-02-16       Impact factor: 4.530

6.  Shati/Nat8l Overexpression Improves Cognitive Decline by Upregulating Neuronal Trophic Factor in Alzheimer's Disease Model Mice.

Authors:  Kakeru Chino; Naotaka Izuo; Hiroshi Noike; Kyosuke Uno; Tomoharu Kuboyama; Chihiro Tohda; Shin-Ichi Muramatsu; Atsumi Nitta
Journal:  Neurochem Res       Date:  2022-06-27       Impact factor: 4.414

7.  Stimulation-induced transient changes in neuronal activity, blood flow and N-acetylaspartate content in rat prefrontal cortex: a chemogenetic fMRS-BOLD study.

Authors:  Morris H Baslow; Christopher K Cain; Robert Sears; Donald A Wilson; Alvin Bachman; Scott Gerum; David N Guilfoyle
Journal:  NMR Biomed       Date:  2016-10-03       Impact factor: 4.044

Review 8.  The therapeutic and diagnostic potential of the prostate specific membrane antigen/glutamate carboxypeptidase II (PSMA/GCPII) in cancer and neurological disease.

Authors:  James C Evans; Meenakshi Malhotra; John F Cryan; Caitriona M O'Driscoll
Journal:  Br J Pharmacol       Date:  2016-09-23       Impact factor: 8.739

9.  Immunohistological and electrophysiological evidence that N-acetylaspartylglutamate is a co-transmitter at the vertebrate neuromuscular junction.

Authors:  Kathryn K Walder; Steve B Ryan; Tomasz Bzdega; Rafal T Olszewski; Joseph H Neale; Clark A Lindgren
Journal:  Eur J Neurosci       Date:  2012-11-08       Impact factor: 3.386

10.  Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome.

Authors:  Zachary J Reitman; Genglin Jin; Edward D Karoly; Ivan Spasojevic; Jian Yang; Kenneth W Kinzler; Yiping He; Darell D Bigner; Bert Vogelstein; Hai Yan
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-02       Impact factor: 12.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.